UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure

JACC. Basic to translational science, 2017-08, Vol.2 (4), p.347-354

2017

Volltextzugriff (PDF)

Angiotensin receptor blockers and myocardial infarction

BMJ, 2004-11, Vol.329 (7477), p.1248-1249

International edition, 2004

Volltextzugriff (PDF)

Preliminary appraisal of deformation structures from Great Nicobar Island, Andaman-Sumatra arc system

Results in Earth Sciences, 2023-10, Vol.1, p.100007, Article 100007

2023

Volltextzugriff (PDF)

Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: translational implications

Canadian journal of physiology and pharmacology, 2018-11, Vol.96 (11), p.1184-1187

2018

Volltextzugriff (PDF)

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors

JACC. Basic to translational science, 2020-06, Vol.5 (6), p.632-644

2020

Volltextzugriff (PDF)

EFFICACY AND SAFETY OF EMPAGLIFLOZIN ACCORDING TO BACKGROUND DIURETIC USE IN PATIENTS WITH HEART FAILURE AND A REDUCED EJECTION FRACTION: A SUB-ANALYSIS OF THE EMPEROR-REDUCED CLINICAL TRIAL

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.4020-4020

2023

Volltextzugriff (PDF)

EFFICACY OF EMPAGLIFLOZIN IN HEART FAILURE PATIENTS WITH A HISTORY OF PERIPHERAL ARTERIAL DISEASE: ANALYSIS FROM EMPEROR-POOLED

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.280-280

2023

Volltextzugriff (PDF)

Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis

CMAJ open, 2017-01, Vol.5 (1), p.E152-E177

2017

Volltextzugriff (PDF)

Ross Procedure in Adults for Cardiologists and Cardiac Surgeons

Journal of the American College of Cardiology, 2018-12, Vol.72 (22), p.2761-2777

2018

Volltextzugriff (PDF)

Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome

American journal of preventive cardiology, 2023-09, Vol.15, p.100510, Article 100510

2023

Volltextzugriff (PDF)

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis

ESC Heart Failure, 2022-04, Vol.9 (2), p.942-946

2022

Volltextzugriff (PDF)

Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG

Journal of the American College of Cardiology, 2017, Vol.69 (2), p.119-127

2017

Volltextzugriff (PDF)

Injection Drug Use Endocarditis: An Inner-City Hospital Experience

CJC open (Online), 2021-07, Vol.3 (7), p.896-903

2021

Volltextzugriff (PDF)

Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes

JACC. Basic to translational science, 2019-02, Vol.4 (1), p.98-112

2019

Volltextzugriff (PDF)

Risk of Acute Kidney Injury in Patients Randomized to a Restrictive Versus Liberal Approach to Red Blood Cell Transfusion in Cardiac Surgery: A Substudy Protocol of the Transfusion Requirements in Cardiac Surgery III Noninferiority Trial

Canadian journal of kidney health and disease, 2018-01, Vol.5, p.2054358117749532-2054358117749532

2018

Volltextzugriff (PDF)

Abstract 12337: Mortality Trends in Aortic Valve Stenosis in High-Income Countries: The Impact of Recent Advances in Procedures

Circulation (New York, N.Y.), 2022-11, Vol.146 (Suppl_1)

2022

Volltextzugriff (PDF)

Abstract 15785: Effects of Empagliflozin on Fatty Acid Binding Protein 4 and Body Composition in Patients Without Diabetes but With Risk Factors for Adverse Cardiac Remodeling From the Empa-Heart 2 Cardiolink-7 Randomized Clinical Trial

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Abstract 17840: Impact of Age and Sex on Mortality Trends of Infective Endocarditis in High-Income Countries

Circulation (New York, N.Y.), 2023-11, Vol.148 (Suppl_1)

2023

Volltextzugriff (PDF)

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Metabolism open, 2020-09, Vol.7, p.100039, Article 100039

2020

Volltextzugriff (PDF)

Mid-Term Outcomes of TAVR in Intermediate-Risk Patients

Journal of the American College of Cardiology, 2023-07, Vol.82 (2), p.124-127

2023

Volltextzugriff (PDF)

Empagliflozin Increases Cardiac Energy Production in Diabetes

JACC. Basic to translational science, 2018-10, Vol.3 (5), p.575-587

2018

Volltextzugriff (PDF)

Prevention of Heart Failure With SGLT-2 Inhibition

Journal of the American College of Cardiology, 2018-06, Vol.71 (22), p.2507-2510

2018

Volltextzugriff (PDF)

Mitral-Valve Repair for Mitral-Valve Prolapse

The New England journal of medicine, 2009-12, Vol.361 (23), p.2261-2269

2009

Volltextzugriff (PDF)

Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

American journal of preventive cardiology, 2020-09, Vol.3, p.100082, Article 100082

2020

Volltextzugriff (PDF)

Should Bioprosthetic Aortic Valves Be Routinely Anticoagulated?

Journal of the American College of Cardiology, 2019-09, Vol.74 (9), p.1201-1204

2019

Volltextzugriff (PDF)

1 – 25 von 435

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(344)
Mit Volltextzugriff
(354)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(37)
Humans
(37)
Medical Sciences
(29)
Diabetes
(21)
Cardiology
(19)
Heart Failure
(17)
Cardiovascular
(16)
Cardiology. Vascular System
(15)
Cardiovascular Disease
(14)
Internal Medicine
(13)
Obesity
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Atherosclerosis
(11)
Diabetes Mellitus
(10)
Mortality
(10)
Surgery
(10)
Animals
(9)
Female
(9)
Heart
(9)
Male
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(16)
... seit 30 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Empagliflozin Prevents Worsening of Cardiac Function in an Experimental Model of Pressure Overload-Induced Heart Failure

Angiotensin receptor blockers and myocardial infarction

Preliminary appraisal of deformation structures from Great Nicobar Island, Andaman-Sumatra arc system

Empagliflozin improves cardiorespiratory fitness in type 2 diabetes: translational implications

Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors

EFFICACY AND SAFETY OF EMPAGLIFLOZIN ACCORDING TO BACKGROUND DIURETIC USE IN PATIENTS WITH HEART FAILURE AND A REDUCED EJECTION FRACTION: A SUB-ANALYSIS OF THE EMPEROR-REDUCED CLINICAL TRIAL

EFFICACY OF EMPAGLIFLOZIN IN HEART FAILURE PATIENTS WITH A HISTORY OF PERIPHERAL ARTERIAL DISEASE: ANALYSIS FROM EMPEROR-POOLED

Dipeptidyl peptidase-4 inhibitors and the risk of heart failure: a systematic review and meta-analysis

Ross Procedure in Adults for Cardiologists and Cardiac Surgeons

Generalizability of REDUCE-IT eligibility criteria in a large diabetes cardiovascular outcomes trial: A post hoc subgroup analysis of EMPA-REG outcome

Sodium‐glucose cotransporter 2 inhibitors in heart failure with reduced or preserved ejection fraction: a meta‐analysis

Dual Antiplatelet Therapy Versus Aspirin Monotherapy in Diabetics With Multivessel Disease Undergoing CABG

Injection Drug Use Endocarditis: An Inner-City Hospital Experience

Circulating Pro-Vascular Progenitor Cell Depletion During Type 2 Diabetes

Risk of Acute Kidney Injury in Patients Randomized to a Restrictive Versus Liberal Approach to Red Blood Cell Transfusion in Cardiac Surgery: A Substudy Protocol of the Transfusion Requirements in Cardiac Surgery III Noninferiority Trial

Abstract 12337: Mortality Trends in Aortic Valve Stenosis in High-Income Countries: The Impact of Recent Advances in Procedures

Abstract 15785: Effects of Empagliflozin on Fatty Acid Binding Protein 4 and Body Composition in Patients Without Diabetes but With Risk Factors for Adverse Cardiac Remodeling From the Empa-Heart 2 Cardiolink-7 Randomized Clinical Trial

Abstract 17840: Impact of Age and Sex on Mortality Trends of Infective Endocarditis in High-Income Countries

Does empagliflozin modulate the autonomic nervous system among individuals with type 2 diabetes and coronary artery disease? The EMPA-HEART CardioLink-6 Holter analysis

Mid-Term Outcomes of TAVR in Intermediate-Risk Patients

Empagliflozin Increases Cardiac Energy Production in Diabetes

Prevention of Heart Failure With SGLT-2 Inhibition

Mitral-Valve Repair for Mitral-Valve Prolapse

Reduction of Revascularizations in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Should Bioprosthetic Aortic Valves Be Routinely Anticoagulated?

Aktive Filter

Suchergebnisse filtern